Evaluation of the safety and immunogenicity of synthetic Aβ (AN1792) in patients with AD

Bayer, A. J. , Wilkinson, D. , Paterson, K. R. , Jenkins, L. , Bullock, R. , Donoghue, S. , Millais, S. B. and Jones, R. (2005) Evaluation of the safety and immunogenicity of synthetic Aβ (AN1792) in patients with AD. Neurology, 64. pp. 94-101.

Full text not available from this repository


Item Type:Article
Uncontrolled Keywords:AN1792 Alzheimer's Dementia
Faculty/Department:Faculty of Health and Life Sciences
~Pre-2012 Faculty Structure > Faculty of Health and Life Sciences
~Pre-2010 Faculty Structure > Health and Life Sciences > School of Health and Social Care
ID Code:2651
Deposited By: H. Upload account
Deposited On:21 Jan 2010 13:09
Last Modified:22 Nov 2012 15:28

Repository Staff Only: item control page
Copyright 2013 © UWE better together